64 episodes

On a mission to disseminate information to the community and bridge the gap between academia and community oncology in this rapidly changing field of hematology & oncology. Drs. Rahul & Rohit Gosain interview world-renowned hematologists/oncologists to present the practice-changing data in a small bite-sized format where one could immediately apply that information in their daily practice to provide the best cancer care to their patients close to home.

Oncology Brothers Oncology Brothers

    • Health & Fitness
    • 4.8 • 26 Ratings

On a mission to disseminate information to the community and bridge the gap between academia and community oncology in this rapidly changing field of hematology & oncology. Drs. Rahul & Rohit Gosain interview world-renowned hematologists/oncologists to present the practice-changing data in a small bite-sized format where one could immediately apply that information in their daily practice to provide the best cancer care to their patients close to home.

    • video
    Dr. Hope Rugo discusses Capivasertib FDA Approval based on CAPItello-291 Study

    Dr. Hope Rugo discusses Capivasertib FDA Approval based on CAPItello-291 Study

    In this discussion with Dr. Hope Rugo, we covered her study Capitello-291, which led to the approval of Capivasertib in hormone receptor-positive breast cancer with AKT1, PTEN, and PIK3CA mutations, which are seen in 40-50% of the cases. We touched base on sequencing of this therapy, and important clinical pearls around the side effect management associated with this drug.

    • 21 min
    • video
    How to Treat HR+ Breast Cancer with Dr. Virginia Kaklamani | Onc Brothers

    How to Treat HR+ Breast Cancer with Dr. Virginia Kaklamani | Onc Brothers

    In discussion with Dr. Virginia Kaklamani, we cover treatment algorithm of HR+ breast cancer. We covered the current standard of care treatment options for HR+ breast cancer.
     
    #HER2 #Sensitive #Breast #Cancer #2024 #oncology #oncbrothers
     
    Website: http://www.oncbrothers.com/
    Twitter: https://twitter.com/oncbrothers
    Contact us at info@oncbrothers.com

    • 21 min
    • video
    GU ASCO 2024 Highlights with Dr. Tian Zhang – CONTACT-02, BRCAAway, AMBASSADOR, Keynote-564

    GU ASCO 2024 Highlights with Dr. Tian Zhang – CONTACT-02, BRCAAway, AMBASSADOR, Keynote-564

    In discussion with Dr. Tian Zhang, covering the Genitourinary ASCO 2024 meeting highlights from the Community Oncology perspective. We covered 4 important practice informing studies from GU ASCO with Dr. Zhang:
    - CONTACT-02: Phase 3 study of cabozantinib plus atezolizumab vs second novel hormonal therapy in patients with metastatic castration-resistant prostate cancer
    - BRCAAway: A randomized phase 2 trial of abiraterone, olaparib, or abiraterone + olaparib in patients with metastatic castration-resistant prostate cancer bearing homologous recombination-repair mutations
    - AMBASSADOR: Phase III randomized adjuvant study of pembrolizumab in muscle-invasive and locally advanced urothelial carcinoma vs observation
    - Keynote-564: Overall survival results from the phase 3 KEYNOTE-564 study of adjuvant pembrolizumab versus placebo for the treatment of clear cell renal cell carcinoma

    • 17 min
    • video
    How to treat HER2+ Breast Cancer in 2024 with Dr. Harold Burstein

    How to treat HER2+ Breast Cancer in 2024 with Dr. Harold Burstein

    In discussion with Dr. Harold Burstein, we cover treatment algorithm of HER2+ breast cancer. We covered the current standard of care treatment options for HER2+ breast cancer.
     
    #HER2 #Sensitive #Breast #Cancer #2024 #oncology #oncbrothers
     
    Website: http://www.oncbrothers.com/
    Twitter: https://twitter.com/oncbrothers
    Contact us at info@oncbrothers.com

    • 22 min
    • video
    GI ASCO 2024 Highlights with Dr. Pamela Kunz – CheckMate 8HW, EMERALD-1, NETTER-2

    GI ASCO 2024 Highlights with Dr. Pamela Kunz – CheckMate 8HW, EMERALD-1, NETTER-2

    In discussion with Dr. Pamela Kunz, covering the Gastroenterology ASCO 2024 meeting highlights from Community Oncology perspective. We covered 3 important practice informing studies from GI ASCO with Dr. Kunz:
    - CheckMate 8HW: Nivolumab plus ipilimumab vs chemotherapy as first-line (1L) treatment for microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) metastatic colorectal cancer
    - EMERALD-1: A phase 3, randomized, placebo-controlled study of transarterial chemoembolization combined with durvalumab with or without bevacizumab in participants with unresectable hepatocellular carcinoma eligible for embolization
    - NETTER-2: [177Lu]Lu-DOTA-TATE in newly diagnosed patients with advanced grade 2 and grade 3, well-differentiated gastroenteropancreatic neuroendocrine tumors

    • 21 min
    • video
    How to Treat Triple Negative Breast Cancer | Dr. Ruth O'Regan Chair & Dr. Anna Weiss

    How to Treat Triple Negative Breast Cancer | Dr. Ruth O'Regan Chair & Dr. Anna Weiss

    Discussing the management using the algorithm of Triple Negative Breast Cancer (TNBC) - with Dr. Ruth O'Regan Chair of medicine Charles A. Dewey Professor at the University of Rochester Wilmot Cancer Institute & Dr. Anna Weiss Associate Professor - Department of Surgery, Oncology Wilmot Cancer Institute.

    • 18 min

Customer Reviews

4.8 out of 5
26 Ratings

26 Ratings

Mudpiles ,

Stay up to date in oncology

THANK YOU! I can’t stress how important your podcast has been for me to stay up to date in this ever changing field. Your podcast has helped me stay on top of all major updates - which has been translating in helping my patients. You two brothers have been doing an amazing job!

Little bubbles1234 ,

Excellent!!!

Such a valuable podcast!! Kudos Oncology Brothers!!

GreatGatsby78 ,

Excellent resource

Enjoy these to the point high yield discussions. Would recommend this to any practicing medical oncologists or APPs in this field.

Top Podcasts In Health & Fitness

Scicomm Media
iHeartPodcasts
Ten Percent Happier
Peter Attia, MD
iHeartPodcasts
Ramsey Network

You Might Also Like

Sam and Karine
Vinay Prasad, MD MPH
Research To Practice
Dr Neil Love
Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff
The Curbsiders Internal Medicine Podcast